[HTML][HTML] Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries
S Kiatpongsan, JJ Kim - PLoS One, 2014 - journals.plos.org
Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
S Kiatpongsan, JJ Kim - PLoS ONE, 2014 - dash.harvard.edu
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
[PDF][PDF] Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
S Kiatpongsan, JJ Kim - 2014 - Citeseer
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries.
S Kiatpongsan, JJ Kim - Plos one, 2014 - europepmc.org
Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries
S Kiatpongsan, JJ Kim - PloS one, 2014 - pubmed.ncbi.nlm.nih.gov
Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
[HTML][HTML] Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
S Kiatpongsan, JJ Kim - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
[PDF][PDF] Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
S Kiatpongsan, JJ Kim - 2014 - pdfs.semanticscholar.org
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
[PDF][PDF] Costs and Cost
S Kiatpongsan, JJ Kim - 2014 - core.ac.uk
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two east African countries.
S Kiatpongsan, JJ Kim - 2014 - cabidigitallibrary.org
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries.
S Kiatpongsan, JJ Kim - PLoS ONE, 2014 - search.ebscohost.com
Background: Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …